Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00694057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Double Blind, Randomized, Placebo-Controlled Study of the Safety, Tolerance and Activity of HE3286 When Administered Orally for 12 Weeks to Adult Patients With Type 2 Diabetes Mellitus
Study identification
- NCT ID
- NCT00694057
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Harbor Therapeutics
- Industry
- Enrollment
- 164 participants
Conditions and interventions
Conditions
Interventions
- HE3286 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2008
- Primary completion
- Dec 31, 2009
- Completion
- Dec 31, 2009
- Last update posted
- Jun 13, 2011
2008 – 2010
United States locations
- U.S. sites
- 22
- U.S. states
- 8
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anaheim | California | 92801 | — |
| Not listed | Anaheim | California | 92805 | — |
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Buena Park | California | 90620 | — |
| Not listed | Burbank | California | 91505 | — |
| Not listed | Carmichael | California | 95608 | — |
| Not listed | Escondido | California | 92025 | — |
| Not listed | Fresno | California | 93726 | — |
| Not listed | Huntington Park | California | 90255 | — |
| Not listed | Long Beach | California | 90806 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | National City | California | 91950 | — |
| Not listed | Roseville | California | 95661 | — |
| Not listed | Chicago | Illinois | 60616 | — |
| Not listed | Baton Rouge | Louisiana | 70808 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | Las Vegas | Nevada | 89148 | — |
| Not listed | El Paso | Texas | 79905 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salt Lake City | Utah | 84107 | — |
| Not listed | Kenosha | Wisconsin | 53142 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00694057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2011 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00694057 live on ClinicalTrials.gov.